Natalie Sinclair

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer

Sara M. Tolaney, Romualdo Barroso‐Sousa, Tanya E. Keenan et al. · JAMA Oncology · 2020 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

Erica L. Mayer, Yue Ren, Nikhil Wagle et al. · Journal of Clinical Oncology · 2024 · 109 citations

Medicine, Oncology, Pharmacology +17

Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice

Duan Chen, Chun‐Mei Zhao, Graham J. Dockray et al. · Gastroenterology · 2000 · 79 citations · Full text

Life Sciences, Endocrinology, Physiology +16

Abstract GS3-06: GS3-06 Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer

Erica L. Mayer, Yue Ren, Nikhil Wagle et al. · Cancer Research · 2023 · 57 citations

Medicine, Oncology, Pharmacology +16

Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism

Natalie Sinclair, Wandong Ai, Raktima Raychowdhury et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2004 · 46 citations

Life Sciences, Cancer Biology, Molecular Biology +17